End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.75 CNY | -1.51% | -6.34% | +27.75% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.75% | 1.86B | - | ||
+18.50% | 67.02B | A- | ||
+3.25% | 49.69B | A- | ||
+19.69% | 42.41B | B+ | ||
+23.39% | 26.65B | A- | ||
+12.41% | 19.62B | C+ | ||
+0.15% | 17.1B | B+ | ||
+3.87% | 15.64B | B+ | ||
-24.51% | 15.43B | A- | ||
-11.83% | 15.3B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300856 Stock
- Ratings Nanjing COSMOS Chemical Co., Ltd.